Global Next-generation Sequencing (NGS) Market report from Global Insight Services is the single authoritative source of intelligence onNext-generation Sequencing (NGS) Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Next-generation sequencing (NGS) is a type of DNA sequencing technology that is used to determine the precise order of nucleotides in a genome. NGS is also used to identify mutations, SNPs, and other variations in a genome.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample-https://www.globalinsightservices.com/request-sample/GIS20191/
Key Trends
The key trends in NGS technology are:
Increased throughput and efficiency: New sequencing technologies are capable of sequencing entire genomes in a single run, and can do so much faster and more cheaply than ever before.
Improved data quality: NGS technologies produce data of much higher quality than older sequencing technologies, making it possible to detect previously undetectable mutations and variations.
Increased applicability: NGS is being used in an ever-widening range of applications, from disease diagnosis and treatment to population genetics and evolutionary studies.
New data analysis methods: As NGS data sets become larger and more complex, new methods of data analysis are needed to make sense of them.
Key Drivers
The key drivers of the Next-generation Sequencing (NGS) market are the declining costs of sequencing, the increasing availability of sequencing platforms, and the increasing demand for sequencing services.
The declining costs of sequencing are driven by the continued development of new sequencing technologies and the increasing scale of sequencing operations. The cost of sequencing a human genome has fallen from over $100 million in 2001 to less than $1,000 in 2016, and is projected to continue to decline in the future.
The increasing availability of sequencing platforms is driven by the continued development of new sequencing technologies and the increasing number of sequencing service providers.
Market Segments
By Product
- Consumables
- Services
By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Other Applications
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Other Technologies
By End User
- Academic and Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Others
Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS20191/
Key Players
- Agilent Technologies, Inc
- BGI Group
- F. Hoffmann-La Roche AG
- Illumina Inc
- Precigen Inc.
- Pacific Biosciences of California, Inc
- PerkinElmer, Inc.
- PierianDx Inc.
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
- Illumina
- QIAGEN
- Eurofins Scientific
- Oxford Nanopore Technologies
- Cepheid
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/